HPV Vaccine

A human papilloma virus (HPV) vaccine has become available in China for women between 16 to 26 years old as the country steps up efforts to fight cervical cancer.

The country’s top drug regulator has allowed the new vaccine to enter the Chinese market after meeting certain requirements.

There are three HPV vaccines which cover different kinds of viruses and different age groups from 9 to 45 years old. The new vaccine can help prevent 92.1 percent of all kinds of cervical cancers.

In addition, all HPV vaccines available worldwide can also be purchased in China.

Cervical cancer is caused by a sexually acquired infection with certain types of HPV. There is also evidence linking HPV with other cancers affecting both male and female genitals.

HPV vaccine producers have been asked to develop risk management plans and track their products’ development after entering the market. on April 30.

A total of 317,200 students from Belt and Road countries came to study, up 11.6 percent over 2016, accounting for 65 percent of the total international students in China, according to a ministry statement.

Some Chinese universities have launched programs inspired by the Belt and Road Initiative to attract students from these countries.

Renmin University of China, for instance, has established a new college, named after the Silk